European Medicines Agency (EMA) Patients' and Consumers'(PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting
Table of contents
This year’s first ‘Patient and Consumer’ (PCWP) and ‘Healthcare Professionals’ (HCPWP) Working Parties joint meeting will be introduced by EMA’s new Executive Director.
During the first day, there will be an update on COVID-19 vaccines and therapeutics, on the European Reference Network model in the European Data Space, Advanced Therapy Medicinal Products (ATMPs) and finally on personalised medicine approaches for the next generation of medicines.
On the second day, the PCWP/HCPWP discussion will focus on Big Data and on ICH Guidances on Good Clinical Practice (E6/E8). The final part of the meeting will be dedicated to an overview of the 2020 Satisfaction Survey results on interactions with EMA.
-
List item
Agenda - PCWP/HCPWP joint meeting on 2-3 March 2021 (PDF/177.13 KB)
Draft
First published: 16/02/2021
Last updated: 22/02/2021
EMA/62114/2021 -
List item
Meeting Summary - PCWP HCPWP joint meeting March 2021 (PDF/311.02 KB)
First published: 31/05/2021
EMA/158664/2021 -
List item
Presentation - Update on COVID-19 vaccines and therapeutics (M.Cavaleri, EMA) (PDF/1.77 MB)
First published: 17/03/2021 -
List item
Presentation - Pharmacovigilance and public safety updates for COVID-19 vaccines (G.Genov, P.Bahri, EMA) (PDF/830.43 KB)
First published: 17/03/2021 -
List item
Presentation - COVID-19 vaccines outreach strategy (M.Carr, EMA) (PDF/1.05 MB)
First published: 17/03/2021 -
List item
Presentation - EMA's third public stakeholder meeting (N.Bere, EMA) (PDF/361.83 KB)
First published: 17/03/2021 -
List item
Presentation - The European Reference Network model in the European Data Space: Potential collaboration between European research networks and EMA (J.Llinares Garcia, EMA) (PDF/141.65 KB)
First published: 17/03/2021 -
List item
Presentation - The European Reference Network model in the European Data Space: European Joint Programme on Rare Diseases (R.Nabbout, APHP) (PDF/1.55 MB)
First published: 17/03/2021 -
List item
Presentation - Timely patient access to Advanced Therapy Medicinal Products (ATMPs) (M.Schüssler-Lenz, CAT) (PDF/1.15 MB)
First published: 17/03/2021 -
List item
Presentation - Personalised medicine approaches for the next generation of medicines (E.Moltzen, IC PerMed) (PDF/2.03 MB)
First published: 17/03/2021 -
List item
Presentation - Implementation of HMA-EMA Big Data Steering Group deliverables (P.Arlett, EMA; N.Brun, DKMA) (PDF/1.15 MB)
First published: 17/03/2021 -
List item
Presentation - Good Clinical Practice (F.Sweeney, EMA) (PDF/588.6 KB)
First published: 17/03/2021 -
List item
Presentation - EMA/FDA Patient-Focused Drug Development ICH Reflection Paper (M.Bonelli, EMA) (PDF/381.44 KB)
First published: 17/03/2021 -
List item
Presentation - Satisfaction survey: What fo the 2020 results tell us? (M.Mavris, EMA) (PDF/435.19 KB)
First published: 17/03/2021